Dear Sir,

Since the onset of COVID-19 pandemics, our lives and sanitary systems changed to reduce contagion and permit patients\' healthcare. The initial SARS-CoV-2 breakout forced the Italian Government to limit the hospital access to emergencies and oncological patients. In our proctologic outpatient clinic, during *lockdown phase*, pelvic floor rehabilitation appointments were canceled, and patients quality of life overshadowed. Remote consultations reduced admissions only to proctologic emergencies not showing any respiratory symptoms. Despite the suggested precautions, our physicians come in close contact with undetected asymptomatic COVID-19 patients, attending our centre for acute anal pain or bleeding. Thus, in the current *reopening phase* facing an increased hospital attendance, it appears crucial to screen all patients before the admittance, or, in case of unavailability of tests, to consider each patient as positive, adopting all the protective precautions of COVID-19 wards. Besides, the sudden evidence of viral RNA traces in COVID-19 patients' stool \[[@bib1]\] long after negativity of rhino-oro-pharyngeal swab, made proctologists safety challenging in phase 2. Even if detection of viral RNA in the stool does not necessarily lead to its infectivity \[[@bib2]\], given the invasive and direct contact generated during digit rectal examinations and anoscopies, proctologists now, might highly require "pandemic proof" behaviors (i.e. telemedicine, use of PPE) as much as anesthesiologists and infectious disease physicians. While the infection control and surveillance until now have been focused on the respiratory system, a possible alternative and emerging scenario involving proctologist in the diagnostic and therapeutic workup might be expected in the cryptic and unpredictable COVID-19 infection.
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